Segment Information and Concentrations

3 Months Ended

Sep. 30, 2011

Notes to Financial Statements

Segment Information and Concentrations

The Company views its operations as two segments: the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors (“Benchtop Laboratory Equipment Operations”), and the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (“Catalyst Research Instruments Operations”).

Segment information is reported as follows:

	Benchtop Laboratory Equipment	Catalyst Research Instruments	Corporate and Other	Consolidated
Three months ended September 30, 2011
Net Sales	$ 1,075,200	$   465,800	$             -	$ 1,541,000
Foreign Sales	608,700	112,600	-	721,300
Segment Profit (Loss)	135,800	(58,600)	-	77,200
Segment Assets	2,621,100	1,078,300	1,333,400	5,032,800
Long-Lived Asset Expenditures	8,200	46,700	-	54,900
Depreciation and Amortization	11,800	35,300	-	47,100
	Benchtop Laboratory Equipment	Catalyst Research Instruments	Corporate and Other	Consolidated
Three months ended September 30, 2010
Net Sales	$ 1,022,100	$   233,400	$             -	$ 1,255,500
Foreign Sales	520,200	26,000	-	546,200
Segment Profit (Loss)	125,000	(131,000)	-	(6,000)
Segment Assets	2,182,500	1,467,300	1,301,500	4,951,300
Segment Asset Expenditures	3,400	1,800	-	5,200
Depreciation and Amortization	13,900	33,500	-	47,400

Approximately 63% and 66% of net sales of benchtop laboratory equipment for the three month periods ended September 30, 2011 and 2010, respectively, were derived from the Company’s main product, the Vortex-Genie 2® mixer, excluding accessories.

Two customers accounted in the aggregate for approximately 20% of the net sales of the Benchtop Laboratory Equipment Operations and 14% of total sales for the three months ended September 30, 2011, and 27% of net sales of the segment and 22% of total sales for the three months ended September 30, 2010. Sales of catalyst research instruments generally comprise a few very large orders averaging $100,000 per order to a limited number of customers, who differ from order to order. Sales to three customers represented approximately 91% of the Catalyst Research Instrument Operations’ net sales and 28% of total sales for the three months ended September 30, 2011. Sales to two different customers represented 75% of the segment’s net sales and 14% of total sales for the year earlier comparable period.

The Company’s foreign sales are principally to customers in Europe and Asia.